Search
for
Sort by
Research 30 of 38
- Permanent chemotherapy-induced alopecia: Case report and review of the literature
- Tufted hair folliculitis in a woman treated with trastuzumab
- Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
- PHARMACOGNOSTIC AND PHARMACOLOGICAL ASPECT OF BACOPA MONNIERI - A REVIEW
- Multiple drugs
- An Overview on Ethanopharmacological Profile of Bacopa Monniera
- Pharma in the bedroom . . . and the kitchen. . . . The pharmaceuticalisation of daily life
- Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients
- Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study
- Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
- Cutaneous drug reactions
- Polarized microscopy in genetic hair disorders: case series
- Kalya Research: Complementary and Alternative Medicine (CAM) Virtual Research Assistant from Biomedical Literature
- Slow progress in prostate cancer
- Index
- Formulation and Evaluation of Herbal Hair Oil
- Integrating herbal components into pharmaceutical formulations for hair woes
- Design and analysis of herbal hair oil
- Focus on herbal home remedies for hair regrowth and loss
- Ethnopharmacology and hair: Indian perspectives
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy